36 results on '"Lange, Andrzej"'
Search Results
2. Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
3. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002
4. Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts
5. Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)
6. Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow
7. Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease
8. Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation
9. Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation
10. Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population
11. Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)
12. Th17 Cells Blood Proportions Are Influenced by Factors Associated with CRP Serum Level Increase and with NOD2/CARD15 Gene Mutation
13. CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses
14. Low Blood Levels of Th17 Cells Are Seen in Patients with aGvHD and Associate with Rather Poor Survival Post HSCT,
15. IL-17 Positive Lymphocytes Predominantly Home At the Mucous Than in the Skin in cGvHD Patients
16. Selective Accumulation of CD45RO+CCR7- in the Marrow Aspirates in Patients with Essential Thrombocythemia
17. Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients
18. TH17 CD4+ CELLS Disappear FROM BLOOD at the Onset of aGVHD
19. Treatment of Elderly Patients with Acute Myeloid Leukemia Adjusted to Age, Performance Status, Organ Function and the Presence of Co-Morbidities. Final Results of the Polish Adult Leukemia Group (PALG) 1/2005 Study.
20. MARROW of Essential Thrombocythemia PATIENTS IS ENRICHED IN Effector Memory CD4+ and CD4+CD25++ Lymphocytes as Compared to BLOOD
21. HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.
22. Proportion of IL-17A Producing CD4+ Cells Increases in Response to Alloreactivity as Part of a Network Involving Memory and Regulatory Cells Post HSCT.
23. HHV-6 Reactivation Lowers the Risk of Acute Graft-Versus-Host Disease but Enhances the Risk of Infections Due to Activation of CD4+FoxP3+ Lymphocytes.
24. HHV6 and EBV Reactivations Associate with Encephalitis in Patients Post Allogeneic Haematopoietic Stem Cell Transplantation
25. Palifermin Does Not Influence the Incidence and Severity of GvHD Nor Long-Term Survival of Patients with Hematological Diseases Undergoing HSCT
26. Increase in Proportion of Th-17 Lymphocytes in Blood Heralds Overt Acute Graft Versus Host Disease in HSCT Patients.
27. Increased Interleukin-17 Proportion in Helper T Cell (Th17) in Patients Post Allogeneic Hematopoietic Stem Cell Transplantation.
28. High-Dose Therapy Followed by Autologous HSCT in Patients with Multiple Myeloma. Results of a Retrospective Multicenter Analysis Conducted by The Polish Myeloma Group.
29. CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.
30. Low Dose Busulfan and ATG with Fludarabine as Conditioning Regimen Was Effective in Sibling and Unrelated Donor HSCT in CML Patients.
31. CCR5 and RANTES/CCL5 Gene Polymorphisms Affect the Risk of EBV Reactivations after Allogeneic HSCT.
32. A High Proportion of CD4+CD25+ Lymphocytes Associates with a Risk of aGvHD and Inversely Correlate with Proportions of CMV and EBV Specific CD8+ Cells in Blood.
33. CCR5 Chemokine Receptor Expression Can Promote Disease Progression in Non-Hodgkin’s Lymphoma.
34. An Evidence That Mesenchymal Stem Cells Are Not Replaced by Peripheral Blood Stem Cell Allografts in CML Patients.
35. Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1Gene Prevailed in Flt3-ITDNegative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease
36. Marrow Cells Cultured in MSC Medium Expand to CD73, CD90 and CD105 Cells of Fibroblast-Like Morphology.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.